Hogan Lovells Secures Patent Victory for HemCon Medical Technologies, Inc. in the U.S. Court of Appeals for the Federal Circuit
28 September 2011
WASHINGTON, D.C., 28 September 2011 – Hogan Lovells announced today that it secured a significant victory for client HemCon Medical Technologies, Inc. in a ruling by the U.S. Court of Appeals for the Federal Circuit. The court’s 26 September decision overturned a damages award in excess of $29 million against HemCon for allegedly infringing a Marine Polymer Technologies, Inc. patent.
In its decision, the U.S. Court of Appeals for the Federal Circuit concluded that the scope of the patent in question, which relates to a polymer that speeds coagulation and clot formation, changed during a re-examination proceeding, therefore entitling HemCon to absolute intervening rights. The decision reverses and vacates the judgment from the lower court against HemCon.
“We are very pleased to have obtained this important victory for our client,” said partner Raymond A. Kurz. “Our team navigated some very interesting and intricate legal issues in order to achieve this terrific result.”
The Hogan Lovells team was led by Washington, D.C. partner Raymond A. Kurz with partner Celine Jimenez Crowson and associates Keith O'Doherty and Robert J. Weinschenk.